ARHI / DIRAS3 Protein|ARHI / DIRAS3蛋白質|廠家現貨|技術資料

ARHI / DIRAS3 Protein Product Information

Synonym : DIRAS3, ARHI, NOEY2, RHOI
Protein Construction: A DNA sequence encoding the human DIRAS3 (O95661) (Met1-Lys225) was expressed with the Fc region of mouse IgG1 at the N-terminus.
Source: Human
Expression Host: Human Cell

ARHI / DIRAS3 Protein QC Testing

Purity: > 85 % as determined by SDS-PAGE SDS-PAGE
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Asp
Molecular Mass: The recombinant human DIRAS3/mFc comprises 461 amino acids and has a predicted molecular mass of 52.1 kDa. The apparent molecular mass of the monomer is approximately 62 kDa in SDS-PAGE under reducing conditions due to glycosylation.
Formulation: Lyophilized from sterile PBS, pH 7.4.
                 1.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
                 2.Please contact us for any concerns or special requirements.

ARHI / DIRAS3 Protein Usage Guide

Storage:  Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution:  A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

ARHI / DIRAS3 Protein Description

ARHI, also known as DIRAS3, belongs to the small GTPase superfamily, Di-Ras family. ARHI gene is a novel tumor suppressor gene located on chromosome 1p31. Downregulation of ARHI expression has been detected in many types of cancer. ARHI is expressed in normal ovarian and breast epithelial cells but not in ovarian and breast cancers. As a suppressor, ARHI is not only an important factor in the pathogenesis of gastric cancer, but also a potential factor for tumor aggravation. ARHI expression in gastric cancer can be employed to indicate favorable prognosis for the disease.

References

Pei XH. et al., 2011, Cell Biol Int. 35 (10): 1019-24.
Lin D. et al., 2011, J Int Med Res. 39 (5): 1870-5.
Wang W. et al., 2012, Oncol Rep. 27 (6): 1953-9.

規格:20ug

關 鍵 詞：ARHI / DIRAS3 Protein，ARHI / DIRAS3蛋白質，廠家現貨，技術資料，實驗室耗材，生化試劑，上海創賽，博飛美科，實驗儀器，廠家

CANSPEC品質提供的ARHI / DIRAS3 Protein|ARHI / DIRAS3蛋白質|廠家現貨|技術資料性能**，其優良的品質滿足您不同實驗的多種需求。

本產品由上海創賽品質提供，歡迎咨詢國內免費服務專線：400-608-7598，更多產品信息請登錄www.getprovidencehotels.com 或 www.4006087598.com